Company: LHI
Filing Date: 2025-08-08
Form Type: F-1/A
Source: 0001213900-25-073646
Chunk: 24

Company: Living Homeopathy International Ltd.
Filing Date: 2025-08-08
Form: F-1/A
Chunk 24
---
 will depend on Living Homeopathy’s future results of operations and cash flow, our capital requirements and surplus, the amount of distributions, if any, received by Living Homeopathy from the subsidiaries, our financial condition, contractual restrictions and other factors deemed relevant by Living Homeopathy’s board of directors. Accordingly, the return on your investment in Living Homeopathy’s Class A Ordinary Shares will likely depend entirely upon any future price appreciation of Living Homeopathy’s Class A Ordinary Shares.

<div align='center'>9</div>

Our equity structure is a direct holding structure, that is, the overseas entity to be listed in the U.S., Living Homeopathy, directly holds 100% of shares of Living Homeopathy Global Ltd, the intermediary holding company incorporated in the British Virgin Islands, or the BVI, which in turns holds all the issued Shares of Living Homeopathy Hong Kong, our operating subsidiary in Hong Kong. Cash is transferred through our organization in the following manner: (i) provided such funding is in the best interests of the Living Homeopathy, funds may be transferred from Living Homeopathy, the holding company incorporated in the Cayman Islands to Living Homeopathy Hong Kong through our BVI intermediary holding company in the form of capital contributions or shareholder loans, as the case may be; and (ii) dividends or other distributions may be paid by Living Homeopathy Hong Kong to Living Homeopathy though our BVI intermediary holding company. Living Homeopathy Hong Kong is permitted under the laws of Hong Kong to provide funding to Living Homeopathy through dividend distribution out of profits available for distribution subject to the Companies Ordinance (Cap. 622, Laws of Hong Kong) and its memorandum and articles of association without restrictions on the amount of the funds or restrictions on foreign exchange. If Living Homeopathy intends to distribute dividends to its shareholders, it will depend on payment of dividends from Living Homeopathy Hong Kong to Living Homeopathy in accordance with the laws and regulations of Hong Kong, and the dividends will be distributed by Living Homeopathy, subject to applicable Cayman Islands restrictions (see “ Dividend Policy” on page 51 of this prospectus), to all shareholders respectively in proportion to the shares they hold, regardless of whether the shareholders are U.S. investors or investors in other countries or regions. If Living Homeopathy incurs debt on its own in the future, the instruments governing such debt may restrict Living Homeopathy’s ability to pay dividends, make distribution or transfer funds to Living Homeopathy. Subject to the Company’s Act and our Amended and Restated Memorandum and